Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
Crossref DOI link: https://doi.org/10.1186/s12876-023-02911-3
Published Online: 2023-08-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cheng, Hui
Li, Qinfang
Text and Data Mining valid from 2023-08-11
Version of Record valid from 2023-08-11
Article History
Received: 15 December 2022
Accepted: 2 August 2023
First Online: 11 August 2023
Declarations
:
: Not applicable.
: The authors declare that they have no competing interests.